CopyMark Law Group
4.9/5
Drawing for D

USPTO serial 74676266

D

Reviewed by CopyMark Law Group

Reg. 2014979Status 710
Filing date
Status date
Registration date
Nov 12, 1996
Examiner
JENKINS JR, CHARLES L
Law office
POST REGISTRATION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with D?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

KATRIN LEWERTOFF

KATRIN LEWERTOFF Ferdinand IP, LLC129 Post Road EastWestport, CT 06880UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001chemicals, namely, acrinol, D-calcium pantothenate, dexpanthenol, pantethine-A, [ disodium adenosine triphosphate, epsilon-aminocaproic acid, ] gamma-aminobutyric acid, pyridoxal 5-phosphate, [ pyridoxine hydrochloride, ] sulfadimethoxine, sulfadimethoxine sodium, sulfamonomethoxine sodium, [ sulpyrine, ] tranexamic acid, sulfamonomethoxine, [ (P-hydroxyphenyl) propionic acid ] for use in the manufacture of pharmaceuticals, cosmetics and food additivesSECTION 8 - CANCELLED—
005[ in vitro diagnostic agents for medical use, diagnostic aids for in vitro biological tests, namely, reagent strips for urine and blood tests, central nervous system depressants, ] ophthalmic use agents, [ anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactics for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, Crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contraceptives; urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago, stiffness and for the treatment of the shoulder; hair remedies, vitamin preparations, namely, dietary supplements, food enriching agents for treating vitamin deficiencies, anticoagulants, enzyme preparations for control of malabsorption and diarrhea, ] anti-cancer preparations, [ anti-sarcoma preparations, ] antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, [ influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelminitics for the treatment of threadworm and for the treatment of toxoplasmosis, excipients, namely, tablet coating polymers soluble in gastric tract, naturally occurring drugs and charred drugs and moxa for the treatment of peptic ulcers, veterinary drugs for the treatment of distemper in dogs, veterinary drugs for the treatment of distomatosis in dogs, veterinary drugs for the treatment of coccidium in chickens, veterinary drugs for the treatment of dysentery in pigs; insecticides for agricultural and/or domestic use, rodenticides for agricultural and/or domestic use, herbicides for agricultural and/or domestic use; antiseptics, drugs for arteriosclerosis, ] oncostatic drugs for the treatment of cancer, [ multienzyme digestants, antifungal antibiotics for the treatment of trichomoniasis and dermatophytosis, anti-parkinsonism agents, minor tranquillizing agents, and antianxiety agents ]SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 23, 2019C8.TCANCELLED SEC. 8 (10-YR)—
Nov 12, 2015REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Feb 6, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 11, 2008MDSMNOTICE OF DESIGN SEARCH CODE MAILED—
Mar 5, 2008ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jan 17, 2007PLGLASSIGNED TO PARALEGAL—
Jan 16, 2007RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Jan 16, 200789AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Jan 16, 200715AKREGISTERED - SEC. 15 ACKNOWLEDGED—
Jan 9, 2007PLGLASSIGNED TO PARALEGAL—
Nov 9, 200689AFREGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED—
Nov 9, 200615AFREGISTERED - SEC. 15 AFFIDAVIT FILED—
Nov 9, 200689AFREGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED—
Nov 9, 2006E89RTEAS SECTION 8 & 9 RECEIVED—
Nov 9, 2006E15RTEAS SECTION 15 RECEIVED—
Sep 13, 2006CFITCASE FILE IN TICRS—
Jul 13, 2006TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 19, 20028.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Sep 3, 2002815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED—
Sep 3, 2002MAILPAPER RECEIVED—
Nov 12, 1996R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 20, 1996PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 19, 1996NPUBNOTICE OF PUBLICATION—
Jun 25, 1996CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 25, 1996CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 31, 1995CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 25, 1995DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance